Passage Bio, Inc. (PASG)
4.96
-0.02
(-0.50%)
USD |
NASDAQ |
Sep 11, 16:00
4.96
0.00 (0.00%)
After-Hours: 17:18
Passage Bio Gross Profit (TTM) : -0.531M for June 30, 2026
Gross Profit (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.531M |
| March 31, 2026 | -0.706M |
| December 31, 2025 | -0.778M |
| September 30, 2025 | -1.32M |
| June 30, 2025 | -1.92M |
| March 31, 2025 | -2.52M |
| December 31, 2024 | -3.125M |
| September 30, 2024 | -3.213M |
| June 30, 2024 | -3.413M |
| March 31, 2024 | -3.591M |
| December 31, 2023 | -3.763M |
| September 30, 2023 | -3.902M |
| June 30, 2023 | -3.831M |
| March 31, 2023 | -3.774M |
| December 31, 2022 | -3.679M |
| September 30, 2022 | -3.402M |
| Date | Value |
|---|---|
| June 30, 2022 | -2.933M |
| March 31, 2022 | -2.215M |
| December 31, 2021 | -1.543M |
| September 30, 2021 | -1.152M |
| June 30, 2021 | -0.967M |
| March 31, 2021 | -0.962M |
| December 31, 2020 | -0.80M |
| September 30, 2020 | -0.567M |
| June 30, 2020 | -0.333M |
| March 31, 2020 | -0.171M |
| December 31, 2019 | -0.134M |
| September 30, 2019 | -0.089M |
| June 30, 2019 | -0.048M |
| March 31, 2019 | -0.012M |
| December 31, 2018 | 0.00 |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| ARS Pharmaceuticals, Inc. | 83.45M |
| ACADIA Pharmaceuticals, Inc. | 1.038B |
| Alnylam Pharmaceuticals, Inc. | 3.827B |
| Anika Therapeutics, Inc. | 75.00M |
| Savara, Inc. | -0.281M |